Insulin Resistance Intervention After Stroke Trial
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if pioglitazone is effective in preventing future
strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.
Phase:
Phase 3
Details
Lead Sponsor:
Yale University
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) Takeda Pharmaceuticals North America, Inc.